Skip to content

Intravesical BCG Study

Intravesical BCG: is the urinary bladder ready to receive it?

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/040806
Enrollment
110
Registered
2022-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH 2. found to have NMIBC (either low risk or high risk). 3. Patient gives consent

Exclusion criteria

Exclusion criteria: 1) Patient who has visible tumour on first or any subsequent cystoscopy. 2) On histopathology found to have muscle invasive bladder cancer. 3) Patient having urinary tract infection before cystoscopy.

Design outcomes

Primary

MeasureTime frame
To define the healing time-frame of the resected area of the bladder after TURBT.Timepoint: 1 year

Secondary

MeasureTime frame
1) To validate a grading system of healing of the bladder mucosa after TURBT. 2) To assess the factors influencing bladder healing. Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Mahendra Pal

Tata Memorial Hospital

mahen1197@gmail.com02224176656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026